Nerve Damage with Two Arthritis Drugs
In a small number of cases, certain arthritis drugs have been associated with serious nervous system problems, according to a recent report from researchers at the US Food and Drug Administration (FDA) and elsewhere in Washington, DC.
They recommend that patients receiving Enbrel (etanercept) or Remicade (infliximab) be monitored by their physicians for neurologic symptoms such as confusion, numbness, changes in vision and difficulty walking.
If neurologic symptoms appear in a patient taking Enbrel or Remicade, the drug should be discontinued immediately, the researchers advise in a recent issue of Arthritis & Rheumatism. The patient should be referred to a neurologist for a thorough examination, they say.